Mark Kozloff to Patient Selection
This is a "connection" page, showing publications Mark Kozloff has written about Patient Selection.
Connection Strength
0.008
-
Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer. Radiat Oncol Investig. 1999; 7(1):49-53.
Score: 0.008